PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacology, University of Michigan, 2301 MSRBIII, 1150 W Medical Center Dr, Ann Arbor, MI, 48190-5606, USA.\', \'Edward F Domino Research Center, University of Michigan, Ann Arbor, MI, 48190, USA.\', \'Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, 48190, USA.\', \'Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48190, USA.\', \'Department of Pharmacology, University of Michigan, 2301 MSRBIII, 1150 W Medical Center Dr, Ann Arbor, MI, 48190-5606, USA. jtraynor@umich.edu.\', \'Edward F Domino Research Center, University of Michigan, Ann Arbor, MI, 48190, USA. jtraynor@umich.edu.\', \'Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, 48190, USA. jtraynor@umich.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-022-08320-y
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 35351926
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all